Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002697520 | SCV003546867 | uncertain significance | Inborn genetic diseases | 2021-03-22 | criteria provided, single submitter | clinical testing | The c.875C>T (p.P292L) alteration is located in exon 8 (coding exon 8) of the BRF1 gene. This alteration results from a C to T substitution at nucleotide position 875, causing the proline (P) at amino acid position 292 to be replaced by a leucine (L). The p.P292L alteration is predicted to be deleterious by in silico analysis. Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |